BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $481,223 | -16.0% | 12,751 | +1.4% | 0.06% | -20.0% |
| Q2 2023 | $572,809 | +45.7% | 12,573 | +29.7% | 0.07% | +34.6% |
| Q1 2023 | $393,132 | -7.0% | 9,693 | +16.9% | 0.05% | -3.7% |
| Q4 2022 | $422,680 | +79.1% | 8,293 | +185.8% | 0.05% | -5.3% |
| Q1 2020 | $236,000 | -7.8% | 2,902 | -5.3% | 0.06% | +18.8% |
| Q4 2019 | $256,000 | -9.5% | 3,064 | -5.5% | 0.05% | -11.1% |
| Q3 2019 | $283,000 | +13.2% | 3,241 | +6.2% | 0.05% | +1.9% |
| Q2 2019 | $250,000 | 0.0% | 3,052 | -0.8% | 0.05% | 0.0% |
| Q1 2019 | $250,000 | +19.6% | 3,076 | -3.3% | 0.05% | +1.9% |
| Q4 2018 | $209,000 | -22.9% | 3,182 | -9.7% | 0.05% | -8.8% |
| Q3 2018 | $271,000 | +1.1% | 3,522 | -14.4% | 0.06% | +21.3% |
| Q1 2018 | $268,000 | +26.4% | 4,113 | -14.4% | 0.05% | -28.8% |
| Q4 2016 | $212,000 | -21.2% | 4,807 | -15.0% | 0.07% | -22.4% |
| Q3 2016 | $269,000 | -62.6% | 5,657 | -64.5% | 0.08% | -62.9% |
| Q2 2016 | $720,000 | +35.1% | 15,944 | +22.8% | 0.23% | +37.1% |
| Q1 2016 | $533,000 | +10.4% | 12,989 | +2.6% | 0.17% | +19.3% |
| Q4 2015 | $483,000 | +33.8% | 12,663 | +15.1% | 0.14% | +32.1% |
| Q3 2015 | $361,000 | -39.2% | 11,000 | +29.4% | 0.11% | -34.6% |
| Q2 2015 | $594,000 | +12.1% | 8,501 | +9.9% | 0.16% | +20.0% |
| Q1 2015 | $530,000 | – | 7,737 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |